Adherex Technologies Inc. (AHX) - Financial and Strategic SWOT Analysis Review

Date: April 22, 2014
Pages: 42
Price:
US$ 125.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: AF1C364CD20EN
Leaflet:

Download PDF Leaflet

Adherex Technologies Inc. (AHX) - Financial and Strategic SWOT Analysis Review
Adherex Technologies Inc. (AHX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Adherex Technologies Inc. (Adherex) is a US-based biopharmaceutical company that focuses on novel cancer treatments. It undertakes the discovery and development of new treatments for cancer focusing on tumor cells and tumor blood vessels. The company has two late stage clinical products: Sodium Thiosulfate (STS) and Eniluracil (EU). STS is a chemical reducing agent undergoing two Phase III clinical trials for the prevention of cisplatin induced hearing loss, or ototoxicity in children. Eniluracil is an oral dihydropyrimidine dehydrogenase (DPD) inhibitor, which is being developed to improve the tolerability and effectiveness of 5-fluorouracil (5-FU).

Adherex Technologies Inc. Key Recent Developments

Mar 31, 2014: Adherex Provides Corporate Update and Fiscal Year Ended December 31, 2013 Financial Results
Nov 22, 2013: Adherex announces closing of private placement
Nov 15, 2013: Adherex reports recent developments and third quarter September 30, 2013 financial results
Nov 15, 2013: Adherex announces private placement of units
Aug 15, 2013: Adherex Announces Corporate Update

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
SECTION 1 - ABOUT THE COMPANY

Adherex Technologies Inc. - Key Facts
Adherex Technologies Inc. - Key Employees
Adherex Technologies Inc. - Key Employee Biographies
Adherex Technologies Inc. - Major Products and Services
Adherex Technologies Inc. - Pharmaceutical Pipeline Products Data
Adherex Technologies Inc., Pipeline Products by Therapy Area
Adherex Technologies Inc., Pipeline Products by Development Phase
Adherex Technologies Inc. - History
Adherex Technologies Inc. - Company Statement
Adherex Technologies Inc. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Adherex Technologies Inc. - Business Description
Adherex Technologies Inc. - Corporate Strategy
Adherex Technologies Inc. - SWOT Analysis
SWOT Analysis - Overview
Adherex Technologies Inc. - Strengths
Strength - Broad Patent Portfolio
Strength - Restructuring Initiatives
Strength - Orphan Drug Designation - Sodium Thiosulfate
Adherex Technologies Inc. - Weaknesses
Weakness - History of Operating Losses
Weakness - Dependence on Third Parties
Adherex Technologies Inc. - Opportunities
Opportunity - Collaborations and Licensing Agreements
Opportunity - Demographic Trends
Opportunity - Growth Potential: Cancer Treatments
Adherex Technologies Inc. - Threats
Threat - Intense Competition
Threat - Industry Consolidation
Threat - Uncertain R&D Outcomes
Adherex Technologies Inc. - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Adherex Technologies Inc., Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014
Adherex Technologies Inc., Pharmaceuticals & Healthcare, Deals By Type, 2008 to YTD 2014
Adherex Technologies Inc., Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Adherex Technologies Inc., Recent Developments
Mar 31, 2014: Adherex Provides Corporate Update and Fiscal Year Ended December 31, 2013 Financial Results
Nov 22, 2013: Adherex announces closing of private placement
Nov 15, 2013: Adherex announces private placement of units
Nov 15, 2013: Adherex reports recent developments and third quarter September 30, 2013 financial results
Aug 15, 2013: Adherex Announces Corporate Update
Aug 09, 2013: Adherex Reports Recent Developments and Second Quarter June 30, 2013 Financial Results
May 13, 2013: Adherex Technologies Reports Q1 2013 Results
Apr 01, 2013: Adherex Technologies Reports 2012 Results

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Adherex Technologies Inc., Key Facts
Adherex Technologies Inc., Key Employees
Adherex Technologies Inc., Key Employee Biographies
Adherex Technologies Inc., Major Products and Services
Adherex Technologies Inc., Number of Pipeline Products by Therapy Area
Adherex Technologies Inc., Number of Pipeline Products by Development Stage
Adherex Technologies Inc., Pipeline Products By Therapy Area and Development Phase
Adherex Technologies Inc., History
Adherex Technologies Inc., Subsidiaries
Adherex Technologies Inc., Key Competitors
Adherex Technologies Inc., Ratios based on current share price
Adherex Technologies Inc., Annual Ratios
Adherex Technologies Inc., Interim Ratios
Adherex Technologies Inc., Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014
Adherex Technologies Inc., Pharmaceuticals & Healthcare, Deals By Type, 2008 to YTD 2014
Adherex Technologies Inc., Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

LIST OF FIGURES

Adherex Technologies Inc., Pipeline Products by Therapy Area
Adherex Technologies Inc., Pipeline Products by Development Phase
Adherex Technologies Inc., Performance Chart (2009 - 2013)
Adherex Technologies Inc., Ratio Charts
Adherex Technologies Inc., Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014
Adherex Technologies Inc., Pharmaceuticals & Healthcare, Deals by Type, 2008 to YTD 2014
Skip to top


Ask Your Question

Adherex Technologies Inc. (AHX) - Financial and Strategic SWOT Analysis Review
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: